Search

Revvity Inc

Закрыт

СекторЗдравоохранение

120.9 -2.37

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

120.52

Макс.

123.8

Ключевые показатели

By Trading Economics

Доход

13M

53M

Продажи

19M

730M

P/E

Средняя по отрасли

62.606

56.597

Прибыль на акцию

1.41

Дивидендная доходность

0.21

Рентабельность продаж

7.329

Сотрудники

11,000

EBITDA

8.8M

189M

Рекомендации

By TipRanks

Рекомендации

Покупка

Прогноз на 12 месяцев

+1.82% upside

Дивиденды

By Acuity

Дивидендная доходность

Средняя по отрасли

0.21%

2.18%

Следующий отчет о доходах

26 окт. 2026 г.

Дата следующей выплаты дивидендов

13 нояб. 2026 г.

Следующая эксдивидендная дата

23 окт. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

1.7B

15B

Предыдущая цена открытия

123.27

Предыдущая цена закрытия

120.9

Новостные настроения

By Acuity

13%

87%

13 / 339 Рейтинг в Healthcare

Revvity Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

9 сент. 2026 г., 20:07 UTC

News
Event

Revvity Inc announced its acquisition of Human Cell Design to enhance its Life Sciences portfolio. Shares are trading lower amid broader market weakness.

8 сент. 2026 г., 20:07 UTC

Revvity Inc shares are lower today, continuing a decline since Friday's close. The stock opened down and remained weak throughout the session.

4 сент. 2026 г., 19:47 UTC

News

Revvity Inc shares are lower amid mixed analyst ratings and price target adjustments. Earlier, shares pulled back from a session high during ongoing market volatility.

3 сент. 2026 г., 20:07 UTC

News

Revvity Inc shares are lower today, reaching a low of -2.18%. Analyst Catherine Ramsey Schulte raised the price target to $144.00 from $131.00.

2 сент. 2026 г., 21:02 UTC

Revvity Inc shares are higher in after-market trading, with no specific news identified. The broader market context includes a disappointing ADP employment report.

1 сент. 2026 г., 19:43 UTC

News

Revvity shares are lower as RBC Capital initiates coverage with a Sector Perform rating and a price target of $135.

31 авг. 2026 г., 20:07 UTC

Revvity Inc shares are lower amid broader market reactions to inflation comments from Warsh at the Jackson Hole Economic Symposium.

28 авг. 2026 г., 22:51 UTC

Revvity Inc shares are trading lower in after-market hours. No specific news was identified to explain this movement amid overall weak market performance.

27 авг. 2026 г., 20:07 UTC

Revvity Inc shares are higher, continuing a trend of gains since Wednesday. The stock remains above its 20-day moving average with four consecutive higher closes.

26 авг. 2026 г., 19:16 UTC

Revvity Inc shares are higher, supported by strong performance metrics and trading above the 20-day moving average. No specific news was identified for this move.

25 авг. 2026 г., 21:02 UTC

Revvity Inc. shares are trading lower in after-market hours, despite remaining above their 20-day moving average and near the upper end of their one-month range.

24 авг. 2026 г., 19:56 UTC

Revvity Inc. shares are lower today, having reached a session low earlier. Broader market pressures include economic concerns related to U.S.-Iran relations.

21 авг. 2026 г., 23:51 UTC

Revvity Inc shares are trading lower in after-market hours. The decline follows a consistent downward trend since Friday's close, despite remaining above the 20-day moving average.

20 авг. 2026 г., 22:01 UTC

Revvity Inc shares are lower in after-market trading, continuing a decline since Thursday's close, despite being above its 20-day moving average.

19 авг. 2026 г., 23:11 UTC

Revvity Inc shares are higher in after-market trading, maintaining gains above the 20-day moving average and near the top of their one-month range.

17 авг. 2026 г., 19:46 UTC

News

RVTY shares lower after analyst downgrades from JPMorgan, Stifel.

14 авг. 2026 г., 20:13 UTC

Revvity Inc shares are lower in after-market trading, with no specific news driving the decline. Broader market trends include a drop in U.S. retail sales.

13 авг. 2026 г., 19:46 UTC

News

Revvity shares are lower despite Q2 revenue and non-GAAP earnings growth. Analysts raised concerns about segment dynamics and competitive challenges following the earnings report.

12 авг. 2026 г., 19:46 UTC

Revvity Inc shares are higher today, supported by positive market sentiment following a favorable inflation report and strong quarterly results from technology companies.

11 авг. 2026 г., 20:13 UTC

Revvity Inc. shares are trading roughly flat after-market hours, with market sentiment influenced by expectations for the upcoming Consumer Price Index report.

10 авг. 2026 г., 22:01 UTC

Revvity Inc shares are trading higher in after-market hours, following broader market dynamics and reduced expectations for Federal Reserve rate hikes.

7 авг. 2026 г., 19:46 UTC

Revvity Inc shares are higher today, maintaining a position above the 20-day moving average and near the upper end of their one-month range.

6 авг. 2026 г., 20:51 UTC

Revvity Inc shares are lower in after-market hours, with no specific news identified. The asset remains above its 20-day moving average.

5 авг. 2026 г., 19:52 UTC

News

Revvity Inc shares are higher as Evercore ISI raises its price target to $126, supported by strong quarterly performance and increased guidance.

4 авг. 2026 г., 19:51 UTC

Social Media
News

Revvity Inc shares are lower following second-quarter results that showed organic revenue growth of 3% and a slight miss on overall revenue estimates.

3 авг. 2026 г., 19:44 UTC

News

Revvity Inc shares are higher ahead of tomorrow's earnings report, with analysts projecting a 3.9% revenue growth year-on-year, recovering from last year's decline.

31 июл. 2026 г., 19:16 UTC

Revvity Inc shares are lower today amid broader market declines, influenced by rising yields and inflation concerns following a significant increase in crude oil prices.

29 июл. 2026 г., 20:08 UTC

Revvity Inc shares are higher today, reflecting a steady upward trend amid rising oil prices and broader market influences. The stock is near its one-month range high.

28 июл. 2026 г., 20:03 UTC

Revvity Inc shares are higher during Tuesday's session, continuing their advance since Monday's close, despite broader market weakness in Asian indices.

27 июл. 2026 г., 21:02 UTC

Revvity Inc shares are lower in after-market hours, continuing a downward trend with three consecutive daily declines. No specific news was identified for the movement.

Сравнение c конкурентами

Изменение цены

Revvity Inc Прогноз

Целевая цена

By TipRanks

1.82% рост

Прогноз на 12 месяцев

Средняя 126.1 USD  1.82%

Максимум 165 USD

Минимум 110 USD

Основано на мнении 11 аналитиков Wall Street, спрогнозировавших целевые цены для Revvity Inc  на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Покупка

11 ratings

4

Покупка

7

Удержание

0

Продажа

Настроения

By Acuity

13 / 339Рейтинг в Здравоохранение

Новостные настроения

Сильные свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Ниже среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Revvity Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat